Erratum: Specific activity of cyclin-dependent kinase I is a new potential predictor of tumour recurrence in stage II colon cancer (British Journal of Cancer (2011) 106 (133-140) DOI:10.1038/bjc.2011.504);Specific activity of cyclin-dependent kinase i is a new potential predictor of tumour recurrence in stage II colon cancer

British Journal of Cancer

Volumn 106, Issue 1, 2012, Pages 133-140

  Zeestraten, E C M ^a   Maak, M ^b   Shibayama, M ^c   Schuster, T ^d   Nitsche, U ^b   Matsushima, T ^c   Nakayama, S ^c   Gohda, K ^c   Friess, H ^b   Van De Velde, C J H ^a   Ishihara, H ^c   Rosenberg, R ^b   Kuppen, P J K ^a   Janssen, K P ^b  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^c SYSMEX CORPORATION   (Japan)

^d TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

biomarker; colorectal cancer; cyclin dependent kinase; metastasis; prognosis

Indexed keywords

CYCLIN DEPENDENT KINASE 1;

ADOLESCENT; ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER SPECIFIC SURVIVAL; COLON CANCER; DISTANT METASTASIS FREE SURVIVAL; ENZYME ACTIVITY; FEMALE; FOLLOW UP; GERMANY; HIGH RISK PATIENT; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTICENTER STUDY; NETHERLANDS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETROSPECTIVE STUDY; TUMOR RECURRENCE;

EID: 84855339541     PISSN: 00070920     EISSN: 15321827     Source Type: Journal    
DOI: 10.1038/bjc.2012.38     Document Type: Erratum

References (51)

1. Arango D, Laiho P, Kokko A, Alhopuro P, Sammalkorpi H, Salovaara R, Nicorici D, Hautaniemi S, Alazzouzi H, Mecklin JP, Jarvinen H, Hemminki A, Astola J, Schwartz Jr S, Aaltonen LA (2005) Gene-expression profiling predicts recurrence in Dukes' C colorectal cancer. Gastroenterology 129: 874-884 (Pubitemid 41242680)
2. Astler VB, Coller FA (1954) The prognostic significance of direct extension of carcinoma of the colon and rectum. Ann Surg 139: 846-852
3. Barrier A, Roser F, Boelle PY, Franc B, Tse C, Brault D, Lacaine F, Houry S, Callard P, Penna C, Debuire B, Flahault A, Dudoit S, Lemoine A (2007) Prognosis of stage II colon cancer by non-neoplastic mucosa gene expression profiling. Oncogene 26: 2642-2648 (Pubitemid 46632008)
4. Begnami MD, Fregnani JH, Nonogaki S, Soares FA (2010) Evaluation of cell cycle protein expression in gastric cancer: cyclin B1 expression and its prognostic implication. Hum Pathol 41: 1120-1127
5. Boutros R, Lobjois V, Ducommun B (2007) CDC25 phosphatases in cancer cells: key players? Good targets? Nat Rev Cancer 7: 495-507 (Pubitemid 46985396)
6. Brown DC, Gatter KC (2002) Ki67 protein: the immaculate deception? Histopathology 40: 2-11 (Pubitemid 34107377)
7. Daidone MG, Silvestrini R (2001) Prognostic and predictive role of proliferation indices in adjuvant therapy of breast cancer. J Natl Cancer Inst Monogr 30: 27-35
8. Duffy MJ, Van Dalen A, Haglund C, Hansson L, Holinski-Feder E, Klapdor R, Lamerz R, Peltomaki P, Sturgeon C, Topolcan O (2007) Tumour markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines for clinical use. Eur J Cancer 43: 1348-1360 (Pubitemid 46874070)
9. Duffy MJ, Van Dalen A, Haglund C, Hansson L, Klapdor R, Lamerz R, Nilsson O, Sturgeon C, Topolcan O (2003) Clinical utility of biochemical markers in colorectal cancer: European Group on Tumour Markers (EGTM) guidelines. Eur J Cancer 39: 718-727 (Pubitemid 36315986)
10. Fearon ER, Vogelstein B (1990) A genetic model for colorectal tumorigen-esis. Cell 61: 759-767
11. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127(12): 2893-2917
12. French AJ, Sargent DJ, Burgart LJ, Foster NR, Kabat BF, Goldberg R, Shepherd L, Windschitl HE, Thibodeau SN (2008) Prognostic significance of defective mismatch repair and BRAF V600E in patients with colon cancer. Clin Cancer Res 14: 3408-3415
13. Gansauge S, Gansauge F, Ramadani M, Stobbe H, Rau B, Harada N, Beger HG (1997) Overexpression of cyclin D1 in human pancreatic carcinoma is associated with poor prognosis. Cancer Res 57: 1634-1637 (Pubitemid 27199649)
14. Gunderson LL, Jessup JM, Sargent DJ, Greene FL, Stewart AK (2010) Revised TN categorization for colon cancer based on national survival outcomes data. J Clin Oncol 28: 264-271
15. Gunderson LL, Sargent DJ, Tepper JE, Wolmark N, O'Connell MJ, Begovic M, Allmer C, Colangelo L, Smalley SR, Haller DG, Martenson JA, Mayer RJ, Rich TA, Ajani JA, MacDonald JS, Willett CG, Goldberg RM (2004) Impact of T and N stage and treatment on survival and relapse in adjuvant rectal cancer: a pooled analysis. J Clin Oncol 22: 1785-1796 (Pubitemid 41095168)
16. Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100: 57-70 (Pubitemid 30046295)
17. Hothorn T, Zeileis A (2008) Generalized maximally selected statistics. Biometrics 64: 1263-1269
18. Ishihara H, Yoshida T, Kawasaki Y, Kobayashi H, Yamasaki M, Nakayama S, Miki E, Shohmi K, Matsushima T, Tada S, Torikoshi Y, Morita M, Tamura S, Hino Y, Kamiyama J, Sowa Y, Tsuchihashi Y, Yamagishi H, Sakai T (2005) A new cancer diagnostic system based on a CDK profiling technology. Biochim Biophys Acta 1741: 226-233 (Pubitemid 41338667)
19. Kahlenberg MS, Sullivan JM, Witmer DD, Petrelli NJ (2003) Molecular prognostics in colorectal cancer. Surg Oncol 12: 173-186 (Pubitemid 37083579)
20. Kim SJ, Nakayama S, Miyoshi Y, Taguchi T, Tamaki Y, Matsushima T, Torikoshi Y, Tanaka S, Yoshida T, Ishihara H, Noguchi S (2008) Determination of the specific activity of CDK1 and CDK2 as a novel prognostic indicator for early breast cancer. Ann Oncol 19: 68-72
21. Korenaga D, Takesue F, Yasuda M, Honda M, Nozoe T, Inutsuka S (2002) The relationship between cyclin B1 overexpression and lymph node metastasis in human colorectal cancer. Surgery 131: S114-S120 (Pubitemid 34118626)
22. Kozak KR, Moody JS (2008) The impact of T and N stage on long-term survival of rectal cancer patients in the community. J Surg Oncol 98: 161-166
23. Lin YH, Friederichs J, Black MA, Mages J, Rosenberg R, Guilford PJ, Phillips V, Thompson-Fawcett M, Kasabov N, Toro T, Merrie AE, Van Rij A, Yoon HS, McCall JL, Siewert JR, Holzmann B, Reeve AE (2007) Multiple gene expression classifiers from different array platforms predict poor prognosis of colorectal cancer. Clin Cancer Res 13: 498-507 (Pubitemid 46225355)
24. Locker GY, Hamilton S, Harris J, Jessup JM, Kemeny N, MacDonald JS, Somerfield MR, Hayes DF, Bast Jr RC (2006) ASCO 2006 update of recommendations for the use of tumor markers in gastrointestinal cancer. J Clin Oncol 24: 5313-5327 (Pubitemid 46631379)
25. Malumbres M, Barbacid M (2009) Cell cycle, CDKs and cancer: a changing paradigm. Nat Rev Cancer 9: 153-166
26. Michels JJ, Marnay J, Delozier T, Den oux Y, Chasle J (2004) Proliferative activity in primary breast carcinomas is a salient prognostic factor. Cancer 100: 455-464 (Pubitemid 38124761)
27. Murakami H, Furihata M, Ohtsuki Y, Ogoshi S (1999) Determination of the prognostic significance of cyclin B1 overexpression in patients with esophageal squamous cell carcinoma. Virchows Arch 434: 153-158 (Pubitemid 29184993)
28. Murphy KM, Zhang S, Geiger T, Hafez MJ, Bacher J, Berg KD, Eshleman JR (2006) Comparison of the microsatellite instability analysis system and the Bethesda panel for the determination of microsatellite instability in colorectal cancers. J Mol Diagn 8: 305-311 (Pubitemid 44063806)
29. O'Connell JB, Maggard MA, Ko CY (2004) Colon cancer survival rates with the new American Joint Committee on Cancer sixth edition staging. J Natl Cancer Inst 96: 1420-1425 (Pubitemid 39429665)
30. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55: 74-108 (Pubitemid 40372904)
31. Pereg Y, Liu BY, O'Rourke KM, Sagolla M, Dey A, Komuves L, French DM, Dixit VM (2010) Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A. Nat Cell Biol 12(4): 400-406
32. Poston GJ, Figueras J, Giuliante F, Nuzzo G, Sobrero AF, Gigot JF, Nordlinger B, Adam R, Gruenberger T, Choti MA, Bilchik AJ, Van Cutsem EJ, Chiang JM, D'Angelica MI (2008) Urgent need for a new staging system in advanced colorectal cancer. J Clin Oncol 26: 4828-4833
33. Peters MG, Vidal MC, Gimenez L, Mauro L, Armanasco E, Cresta C, Bal de Kier JE, Puricelli L (2004) Prognostic value of cell cycle regulator molecules in surgically resected stage I and II breast cancer. Oncol Rep 12: 1143-1150
34. Pichler M, Balic M, Stadelmeyer E, Ausch C, Wild M, Guelly C, Bauernhofer T, Samonigg H, Hoefler G, Dandachi N (2009) Evaluation of high-resolution melting analysis as a diagnostic tool to detect the BRAF V600E mutation in colorectal tumors. J Mol Diagn 11: 140-147
35. Roth AD, Tejpar S, Delorenzi M, Yan P, Fiocca R, Klingbiel D, Dietrich D, Biesmans B, Bodoky G, Barone C, Aranda E, Nordlinger B, Cisar L, Labianca R, Cunningham D, Van Cutsem E, Bosman F (2010) Prognostic role of KRAS and BRAF in stage II and III resected colon cancer: results of the translational study on the PETACC-3, EORTC 40993, SAKK 60-00 trial. J Clin Oncol 28: 466-474
36. Roukos DH, Murray S, Briasoulis E (2007) Molecular genetic tools shape a roadmap towards a more accurate prognostic prediction and personalized management of cancer. Cancer Biol Ther 6: 308-312 (Pubitemid 47328293)
37. Salazar R, Roepman P, Capella G, Moreno V, Simon I, Dreezen C, Lopez-Doriga A, Santos C, Marijnen C, Westerga J, Bruin S, Kerr D, Kuppen P, van de Velde CJH, Morreau H, Van Velthuysen L, Glas AM, Van't Veer LJ, Tollenaar R (2010) Gene expression signature to improve prognosis prediction of stage II and III colorectal cancer. J Clin Oncol 2010: 30
38. Sjostrom J, Blomqvist C, Heikkila P, Boguslawski KV, Raisanen-Sokolowski A, Bengtsson NO, Mjaaland I, Malmstrom P, Ostenstadt B, Bergh J, Wist E, Valvere V, Saksela E (2000) Predictive value of p53, mdm-2, p21, and mib-1 for chemotherapy response in advanced breast cancer. Clin Cancer Res 6: 3103-3110 (Pubitemid 30637734)
39. Soria JC, Jang SJ, Khuri FR, Hassan K, Liu D, Hong WK, Mao L (2000) Overexpression of cyclin B1 in early-stage non-small cell lung cancer and its clinical implication. Cancer Res 60(15): 4000-4004 (Pubitemid 30636572)
40. Sutter T, Doi S, Carnevale KA, Arber N, Weinstein IB (1997) Expression of cyclins D1 and E in human colon adenocarcinomas. J Med 28: 285-309 (Pubitemid 28168519)
41. Suzuki T, Urano T, Miki Y, Moriya T, Akahira J, Ishida T, Horie K, Inoue S, Sasano H (2007) Nuclear cyclin B1 in human breast carcinoma as a potent prognostic factor. Cancer Sci 98: 644-651 (Pubitemid 46563439)
42. Takano Y, Kato Y, Van Diest PJ, Masuda M, Mitomi H, Okayasu I (2000) Cyclin D2 overexpression and lack of p27 correlate positively and cyclin E inversely with a poor prognosis in gastric cancer cases. Am J Pathol 156: 585-594 (Pubitemid 30643814)
43. Takemasa I, Yamamoto H, Sekimoto M, Ohue M, Noura S, Miyake Y, Matsumoto T, Aihara T, Tomita N, Tamaki Y, Sakita I, Kikkawa N, Matsuura N, Shiozaki H, Monden M (2000) Overexpression of CDC25B phosphatase as a novel marker of poor prognosis of human colorectal carcinoma. Cancer Res 60: 3043-3050 (Pubitemid 30395833)
44. Tejpar S, Bertagnolli M, Bosman F, Lenz HJ, Garraway L, Waldman F, Warren R, Bild A, Collins-Brennan D, Hahn H, Harkin DP, Kennedy R, Ilyas M, Morreau H, Proutski V, Swanton C, Tomlinson I, Delorenzi M, Fiocca R, Van Cutsem E, Roth A (2010) Prognostic and predictive biomarkers in resected colon cancer: current status and future perspectives for integrating genomics into biomarker discovery. Oncologist 15: 390-404
45. Timofeev O, Cizmecioglu O, Settele F, Kempf T, Hoffmann I (2010) Cdc25 phosphatases are required for timely assembly of CDK1-cyclin B at the G2/M transition. J Biol Chem 285(22): 16978-16990
46. Van Cutsem E, Oliveira J (2009) Primary colon cancer: ESMO clinical recommendations for diagnosis, adjuvant treatment and follow-up. Ann Oncol 20: 49-50
47. Van Diest PJ, Michalides RJ, Jannink L, van der Valk P, Peterse HL, de Jong JS, Meijer CJ, Baak JP (1997) Cyclin D1 expression in invasive breast cancer. Correlations and prognostic value. Am J Pathol 150: 705-711 (Pubitemid 27073797)
48. van Nes JG, Smit VT, Putter H, Kuppen PJ, Kim SJ, Daito M, Ding J, Shibayama M, Numada S, Gohda K, Matsushima T, Ishihara H, Noguchi S, van de Velde CJH (2009) Validation study of the prognostic value of cyclin-dependent kinase (CDK)-based risk in Caucasian breast cancer patients. Br J Cancer 100: 494-500
49. Walther A, Houlston R, Tomlinson I (2008) Association between chromosomal instability and prognosis in colorectal cancer: a meta-analysis. Gut 57: 941-950 (Pubitemid 351919529)
50. Webber EM, Lin JS, Evelyn PW (2010) Oncotype DX tumor gene expression profiling in stage II colon cancer. Application: prognostic, risk prediction. PLoS Curr 2: pii: RRN1177
51. Yoshida T, Tanaka S, Mogi A, Shitara Y, Kuwano H (2004) The clinical significance of Cyclin B1 and Wee1 expression in non-small-cell lung cancer. Ann Oncol 15: 252-256 (Pubitemid 38262624)